Allay Therapeutics
Allay Therapeutics is a clinical-stage biopharmaceutical company with operations in San Jose, California and Singapore, developing ultra-sustained, non-opioid analgesic products for post-surgical pain management. Its platform is a tunable drug-biopolymer architecture that pairs validated non-opioid analgesics with dissolvable biopolymers to release pain relief at a targeted surgical site over weeks rather than days, and can be tuned for constant release (chronic pain such as osteoarthritis) or pulsed release (cyclic pain such as gout). Lead candidate ATX-101 is a bupivacaine-based implant placed directly at the surgical site during total knee replacement (TKA), targeting the three-day to two-week analgesia gap that drives breakthrough pain and opioid use; it holds FDA Breakthrough Therapy Designation and entered a pivotal Phase 2b registration trial with first patients dosed in 2025. Additional programs (ATX-201, ATX-301, ATX-401, ATX-501) span new formulations, injectables, additional clinical indications and on-demand anesthetic delivery. The company raised a $57.5M Series D plus a venture debt line in 2025 and has a development and commercialization agreement with Maruishi Pharmaceutical for Japan. It is a therapeutics developer, not a software company, and publishes no developer program, API, SDK, or machine-readable interface.
Allay Therapeutics publishes 8 APIs on the APIs.io network, including Comments API, Discovery API, Media API, and 5 more. Tagged areas include Company, Biotechnology, Pharmaceuticals, Pain Management, and Drug Delivery.
Allay Therapeutics’ developer surface includes product news, authentication, and 22 more developer resources.
Kin Score
APIs 8
Individual APIs this provider publishes, each with its own machine-readable definition.
Allay Therapeutics Comments API
Comment collection. Registered and anonymously reachable, but empty — X-WP-Total is 0.
Allay Therapeutics Discovery API
Route, type, taxonomy and status discovery documents.
Allay Therapeutics Media API
Media library. `X-WP-Total` reports 161 attachments, but only one attachment (id 1503) is returned to an anonymous caller; the remainder are attached to non-public parents.
Allay Therapeutics Oembed API
oEmbed 1.0 provider endpoint for www.allaytx.com URLs.
Allay Therapeutics Pages API
Corporate pages. 9 published at harvest time — Home, About Us, Our Science, Pipeline, News, Careers, Contact Us, Privacy Notices, Terms of Service.
Allay Therapeutics Posts API
News archive — press releases, in-the-news coverage, and presentations/publications. 19 posts published at harvest time, spanning 2021-05-13 (company launch with first clinical ...
Allay Therapeutics Search API
Cross-content search across published posts and pages.
Allay Therapeutics Taxonomy API
Categories and tags. Four categories are registered — Press Releases (14), In The News (4), Presentations and Publications (1), Uncategorized (0). The post_tag taxonomy holds th...
Scroll for all 8
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 4
Properties that don't map to a standard resource type